Surgery Partners SGRY 深 滬
已收盤 10-24 16:00:00 美东时间
22.80
+0.830
+3.78%
華盛通- 最 高23.025
- 今 開22.25
- 成交量 142.40万股
- 最 低 22.065
- 昨 收 21.97
- 總市值 29.18亿
- 52周最高 31.89
- 市盈率 靜 --
- 換手率 1.11%
- 52周最低 18.87
- 委 比 -25.49%
- 總股本 1.28亿
- 歷史最高 69.58
- 量 比 1.34
- 振 幅 4.37%
- 歷史最低 4.00
- 每 手 1
- 風險率 2.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Watch hospital stocks as HCA, Community Health post Q3 beats
Hospital stocks are expected to trade higher on Friday after HCA Healthcare (NYSE:HCA), the number one for-profit healthcare provider in the U.S., and its peer Community Health Systems (NYSE:CYH) repo...
10-24 19:57
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $36 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $36 price target.
10-07 21:15
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
Aveanna upgraded at J.P. Morgan on risk-reward setup
J.P. Morgan upgraded Aveanna Healthcare (NASDAQ:AVAH) to Neutral from Underweight and raised its Dec. 26 price target to $10 from $6 on Thursday, noting a balanced risk-reward setup for the home healt...
09-19 00:20
JP Morgan Assumes Surgery Partners at Neutral, Announces Price Target of $27
JP Morgan analyst Benjamin Rossi assumes Surgery Partners (NASDAQ:SGRY) with a Neutral rating and announces Price Target of $27.
09-18 19:04
Surgery Partners Appoints New Chairman After Resignation
An announcement from Surgery Partners ( ($SGRY) ) is now available. On August 4...
08-07 05:51
Surgery Partners Reports Revenue Growth Amid Net Loss
Surgery Partners Inc. ( ($SGRY) ) has released its Q2 earnings. Here is a break...
08-06 12:27
Surgery Partners Affirms FY2025 Sales Guidance of $3.300B-$3.450B vs $3.376B Est
Surgery Partners (NASDAQ:SGRY) affirms FY2025 sales outlook from $3.300 billion-$3.450 billion to $3.300 billion-$3.450 billion vs $3.376 billion estimate.
08-05 19:32
